Literature DB >> 8383706

Herpes simplex virus infection of human fibroblasts and keratinocytes inhibits recognition by cloned CD8+ cytotoxic T lymphocytes.

D M Koelle1, M A Tigges, R L Burke, F W Symington, S R Riddell, H Abbo, L Corey.   

Abstract

CD8+ cytotoxic T lymphocytes (CTL) clones with specificity for herpes simplex virus (HSV) were derived from two donors with genital HSV-2 infection. These CTL clones specifically lysed HSV-infected autologous B lymphoblastoid cells, but not HSV-infected fibroblasts. Exogenous peptide loading sensitized both cell types to lysis by an HSV-specific CTL clone of known specificity. HSV infection rendered fibroblasts refractory to peptide sensitization. HSV infection also rendered fibroblasts and keratinocytes insensitive to lysis by allospecific CD8+ CTL clones. Lysis of B lymphoblastoid cells in this system was only slightly reduced by HSV infection. Reduction of fibroblast allospecific lysis was dose and time dependent and was blocked by acyclovir, indicating the involvement of a late HSV gene product. HSV caused a reduction of fibroblast cell surface HLA class I antigen, at least in part due to reduction of synthesis of heavy chain-beta 2 microglobulin heterodimers. These results suggest that HSV-induced blockade of antigen presentation by cutaneous cells to CD8+ CTL may be a mechanism by which HSV limits or evades the immune response of the host.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8383706      PMCID: PMC288048          DOI: 10.1172/JCI116317

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  47 in total

1.  A monoclonal antibody that recognizes an antigenic determinant shared by HLA A2 and B17.

Authors:  A J McMichael; P Parham; N Rust; F Brodsky
Journal:  Hum Immunol       Date:  1980-09       Impact factor: 2.850

2.  Human T-cell cultures from virus-sensitized donors can mediate virus-specific and HLA-restricted cell lysis.

Authors:  K K Sethi; I Stroehmann; H Brandis
Journal:  Nature       Date:  1980-08-14       Impact factor: 49.962

3.  Pathogenesis of herpes simplex labialis. I. Replication of herpes simplex virus in cultures of epidermal cells from subjects with frequent recurrences.

Authors:  S L Spruance; F S Chow
Journal:  J Infect Dis       Date:  1980-11       Impact factor: 5.226

4.  Enhanced representation of HL-A antigens on human lymphocytes after mitogenesis induced by phytohemagglutinin or Epstein-Barr virus.

Authors:  J M McCune; R E Humphreys; R R Yocum; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

5.  Glycoproteins of herpes simplex virus type 2 as defined by monoclonal antibodies.

Authors:  N Balachandran; D Harnish; W E Rawls; S Bacchetti
Journal:  J Virol       Date:  1982-10       Impact factor: 5.103

6.  Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis.

Authors:  C J Barnstable; W F Bodmer; G Brown; G Galfre; C Milstein; A F Williams; A Ziegler
Journal:  Cell       Date:  1978-05       Impact factor: 41.582

7.  Idiotype-anti-idiotype interactions and the control of the anti-beta (2 leads to 6) polyfructosan response in the mouse: specificity and idiotypy of anti-ABPC48 anti-idiotypic monoclonal antibodies.

Authors:  P Legrain; D Voegtle; G Buttin; P A Cazenave
Journal:  Eur J Immunol       Date:  1981-09       Impact factor: 5.532

8.  HLA-restricted T lymphocyte-mediated cytotoxicity against herpes simplex virus-infected cells in humans.

Authors:  M Yasukawa; T Shiroguchi; Y Kobayashi
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

9.  Nucleotide sequence of the herpes simplex virus type 2 (HSV-2) thymidine kinase gene and predicted amino acid sequence of thymidine kinase polypeptide and its comparison with the HSV-1 thymidine kinase gene.

Authors:  S Kit; M Kit; H Qavi; D Trkula; H Otsuka
Journal:  Biochim Biophys Acta       Date:  1983-11-17

10.  Human histocompatibility determinants and virus antigens: effect of measles virus infection on HLA expression.

Authors:  M V Haspel; M A Pellegrino; P W Lampert; M B Oldstone
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

View more
  23 in total

Review 1.  HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis.

Authors:  A Jacobs; X O Breakefield; C Fraefel
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

2.  Immunodominance among herpes simplex virus-specific CD8 T cells expressing a tissue-specific homing receptor.

Authors:  David M Koelle; Zhi Liu; Christopher L McClurkan; Randal C Cevallos; Jeffrey Vieira; Nancy A Hosken; Clement A Meseda; Devon C Snow; Anna Wald; Lawrence Corey
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-17       Impact factor: 11.205

3.  Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes.

Authors:  D M Koelle; C M Posavad; G R Barnum; M L Johnson; J M Frank; L Corey
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

4.  Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP.

Authors:  R Tomazin; A B Hill; P Jugovic; I York; P van Endert; H L Ploegh; D W Andrews; D C Johnson
Journal:  EMBO J       Date:  1996-07-01       Impact factor: 11.598

5.  Inhibition of major histocompatibility complex class I antigen presentation in pig and primate cells by herpes simplex virus type 1 and 2 ICP47.

Authors:  P Jugovic; A M Hill; R Tomazin; H Ploegh; D C Johnson
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

6.  High frequency of CD8+ cytotoxic T-lymphocyte precursors specific for herpes simplex viruses in persons with genital herpes.

Authors:  C M Posavad; D M Koelle; L Corey
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

7.  Phase I study of a herpes simplex virus type 2 (HSV-2) DNA vaccine administered to healthy, HSV-2-seronegative adults by a needle-free injection system.

Authors:  Ashok Cattamanchi; Christine M Posavad; Anna Wald; Yaela Baine; Jennifer Moses; Terry J Higgins; Richard Ginsberg; Richard Ciccarelli; Lawrence Corey; David M Koelle
Journal:  Clin Vaccine Immunol       Date:  2008-09-10

8.  Human cytomegalovirus-infected cells have unstable assembly of major histocompatibility complex class I complexes and are resistant to lysis by cytotoxic T lymphocytes.

Authors:  A P Warren; D H Ducroq; P J Lehner; L K Borysiewicz
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

9.  Recognition of herpes simplex virus type 2 tegument proteins by CD4 T cells infiltrating human genital herpes lesions.

Authors:  D M Koelle; J M Frank; M L Johnson; W W Kwok
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

10.  Herpes simplex virus type 2 tegument proteins contain subdominant T-cell epitopes detectable in BALB/c mice after DNA immunization and infection.

Authors:  William J Muller; Lichun Dong; Adrian Vilalta; Benjamin Byrd; Kai M Wilhelm; Christopher L McClurkan; Michal Margalith; Chao Liu; David Kaslow; John Sidney; Alessandro Sette; David M Koelle
Journal:  J Gen Virol       Date:  2009-03-04       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.